Clinical research survey results: The key pressures for SMEs and business outlook
The pharma sector is at a crossroads, with major challenges for small and medium-sized businesses driving clinical research. However, there…
All articles by Alexander Love
Alexander Love
-
-
Clinical trial trends in 2025: Investment headwinds, wearables, and targeted AI uses
2025 is set to be another significant year for clinical trials. According to GlobalData’s Clinical Trials database, as of January…
-
Calls for increased education and support for sickle cell blood therapy in US
Sickle cell disease can have a devastating effect on the health of patients. The disease can cause chronic health conditions,…
-
How APIs can unlock automation and efficiencies across eClinical technologies
Clinical trials have always been complex, but the last five to ten years have seen an increase in complexities due…
-
Gamma delta T cells explained: The next medical breakthrough?
Gamma delta (γδ) T cells hold significant potential for unmet medical needs. Yet they are more challenging to source than…
-
The people-first approach transforming eClinical processes
As data management applications become more commonplace across the clinical sphere, and teams search for new ways to use technology…
-
How supervised machine learning optimizes AI use in clinical trials
Artificial intelligence (AI) is widely considered to be the technology that will offer the most benefits for clinical trials. In…
-
The benefits of using a nimble platform from phase to phase
By streamlining data entry and reducing complex paperwork, digital platforms can reduce costs and timelines for clinical trials. While SaaS…
-
Podcast: How drones are transforming the clinical supply chain in Africa
Africa has the highest disease burden of any continent in the world. With arguably the most diverse range of environments,…
-
Why the Importer of Record (IoR) is vital in the clinical supply chain
With imports fundamental to the clinical supply chain, a specialist Importer of Record (IoR) can make all the difference in…